The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis

Md Hasan Zaki1, Peter Vogel, R K Subbarao Malireddi

  • 1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Cancer Cell
|November 19, 2011
PubMed

Insights

NLRP12 (Nod-like receptor 12) normally suppresses inflammation. Mice lacking NLRP12 show increased susceptibility to colon inflammation and colorectal tumors due to unchecked inflammatory pathways.

Area of Science:

  • Immunology
  • Molecular Biology
  • Gastroenterology

Background:

  • The intracellular Nod-like receptor (NLR) family protein NLRP12 is implicated in regulating inflammatory cytokine production.
  • The precise physiological role of NLRP12 in inflammation and associated diseases remains largely uncharacterized.

Purpose of the Study:

  • To investigate the function of NLRP12 in inflammatory conditions, specifically focusing on colitis and colorectal tumorigenesis.
  • To elucidate the molecular mechanisms by which NLRP12 influences inflammatory responses and tumor development.

Main Methods:

  • Analysis of Nlrp12-deficient mice models.
  • Assessment of inflammatory cytokine and chemokine production in the colon.
  • Evaluation of NF-κB and ERK activation pathways in macrophages.
  • Monitoring of colon inflammation and colorectal tumor development.

Main Results:

  • Nlrp12-deficient mice exhibited heightened susceptibility to colon inflammation and colorectal tumorigenesis.
  • Increased production of inflammatory cytokines, chemokines, and tumorigenic factors was observed in Nlrp12-deficient mice.
  • Failure to dampen NF-κB and ERK activation in macrophages contributed to enhanced inflammation and tumor growth.
  • NLRP12 deficiency led to a breakdown in intestinal homeostasis.

Conclusions:

  • NLRP12 plays a critical role in maintaining intestinal homeostasis.
  • NLRP12 acts as a crucial protector against the development of colorectal tumorigenesis.
  • Targeting NLRP12 may offer therapeutic strategies for inflammatory bowel diseases and colorectal cancer.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...